NCT06626919 2026-02-25A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesArcellx, Inc.Phase 1 Recruiting30 enrolled
NCT06381284 2025-03-25Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-AssessmentZS AssociatesCompleted215 enrolled